Who owns Ultragenyx Pharmaceutical Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RARE from SEC Form 13F filings across 266 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 266 institutions disclosed 104.9M shares of Ultragenyx Pharmaceutical Inc. worth $1.58B — about 102.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
266
13F holders
$1.58B
value, 2026 filers
102.7%
of shares outstanding (104.9M sh)
47
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RARE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.4M | $171.8M | 0.0% | 11.2% | +7.3% |
| 2 | RTW INVESTMENTS, LP | 8.5M | $128.2M | 1.3% | 8.4% | +9.4% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.4M | $126.5M | 0.0% | 8.2% | +24.0% |
| 4 | STATE STREET CORP | 7.5M | $113.3M | 0.0% | 7.4% | +22.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | $64.6M | 0.0% | 4.2% | +0.1% |
| 6 | TWO SIGMA INVESTMENTS, LP | 3.1M | $47.1M | 0.0% | 3.1% | -13.6% |
| 7 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.9M | $43.6M | 0.2% | 2.8% | -1.3% |
| 8 | Nantahala Capital Management, LLCNEW | 2.3M | $35.2M | 1.1% | 2.3% | new |
| 9 | GW&K Investment Management, LLC | 2.3M | $34.7M | 0.3% | 2.3% | +55.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $32.7M | 0.0% | 2.1% | -15.7% |
| 11 | GOLDMAN SACHS GROUP INC | 1.9M | $28.8M | 0.0% | 1.9% | +233.0% |
| 12 | Sofinnova Investments, Inc. | 1.8M | $26.4M | 1.1% | 1.7% | +2.1% |
| 13 | Madison Avenue Partners, LPNEW | 1.7M | $25.6M | 1.0% | 1.7% | new |
| 14 | MILLENNIUM MANAGEMENT LLC | 1.5M | $22.8M | 0.0% | 1.5% | +99.5% |
| 15 | Qube Research & Technologies Ltd | 1.3M | $20.2M | 0.0% | 1.3% | +52.5% |
| 16 | Jefferies Financial Group Inc. | 1.3M | $20.1M | 0.1% | 1.3% | +44.1% |
| 17 | TORONTO DOMINION BANK | 1.2M | $18.3M | 0.0% | 1.2% | +192.8% |
| 18 | Krensavage Asset Management, LLC | 1.1M | $17.1M | 6.5% | 1.1% | +191.9% |
| 19 | Trexquant Investment LP | 1.1M | $16.3M | 0.1% | 1.1% | +94.9% |
| 20 | ALGERT GLOBAL LLC | 1.0M | $15.2M | 0.2% | 1% | +158.5% |
| 21 | Russell Investments Group, Ltd. | 944,240 | $14.3M | 0.0% | 0.9% | +20.4% |
| 22 | Rock Springs Capital Management LP | 925,089 | $13.9M | 0.7% | 0.9% | -4.4% |
| 23 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 923,094 | $13.9M | 0.1% | 0.9% | -25.7% |
| 24 | D. E. Shaw & Co., Inc. | 892,102 | $13.4M | 0.0% | 0.9% | -48.4% |
| 25 | NORTHERN TRUST CORP | 875,191 | $13.2M | 0.0% | 0.9% | -4.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.